National Vision Holdings, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
National Vision Holdings, Inc. (EYE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $22.31 million for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-02-26
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-30 was $55.85M, a 1.90% increase year-over-year.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $54.81M, a 115.56% increase year-over-year.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-04-01 was $25.43M.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was $22.31M, a 74.23% increase from fiscal 2018.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $12.80M.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was -$493.00K, a 1273.81% decline from fiscal 2016.
- National Vision Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was $42.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2019-12-28 | $22.31M 10-K · filed 2020-02-26 | |||
| 2019-09-28 | $77.29M 10-Q · filed 2019-11-07 | |||
| 2019-06-29 | $65.87M 10-Q · filed 2019-08-06 | |||
| 2019-03-30 | $55.85M 10-Q · filed 2019-05-09 | |||
| 2018-12-29 | $12.80M 10-K · filed 2020-02-26 | |||
| 2018-09-29 | $44.88M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $30.63M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $54.81M 10-Q · filed 2019-05-09 | |||
| 2017-12-30 | -$493.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $22.91M 10-Q · filed 2018-11-13 | |||
| 2017-07-01 | $20.33M 10-Q · filed 2018-08-14 | |||
| 2017-04-01 | $25.43M 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | $42.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |